Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis.
Hoffman IE, Peene I, Pottel H, Union A, Hulstaert F, Meheus L, Lebeer K, De Clercq L, Schatteman L, Poriau S, Mielants H, Veys EM, De Keyser F. Hoffman IE, et al. Among authors: mielants h. Clin Chem. 2005 Jan;51(1):261-3. doi: 10.1373/clinchem.2004.034728. Epub 2004 Sep 23. Clin Chem. 2005. PMID: 15388633 No abstract available.
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.
Vander Cruyssen B, Hoffman IE, Peene I, Union A, Mielants H, Meheus L, De Keyser F. Vander Cruyssen B, et al. Among authors: mielants h. Ann Rheum Dis. 2007 Mar;66(3):364-9. doi: 10.1136/ard.2006.053470. Epub 2006 Jul 13. Ann Rheum Dis. 2007. PMID: 16840502 Free PMC article.
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F. De Rycke L, et al. Among authors: mielants h. Ann Rheum Dis. 2004 Dec;63(12):1587-93. doi: 10.1136/ard.2003.017574. Ann Rheum Dis. 2004. PMID: 15547083 Free PMC article.
Ankylosing spondylitis and bowel disease.
Baeten D, De Keyser F, Mielants H, Veys EM. Baeten D, et al. Among authors: mielants h. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):537-49. doi: 10.1053/berh.2002.0249. Best Pract Res Clin Rheumatol. 2002. PMID: 12406426 Review.
The gut in the spondyloarthropathies.
Mielants H, Veys EM. Mielants H, et al. J Rheumatol. 1990 Jan;17(1):7-10. J Rheumatol. 1990. PMID: 2179551 Review. No abstract available.
Clinical manifestations in HLA-B27-positive patients.
Joos R, Veys EM, Mielants H, Vandewalle K, De Sutter P, Herman H, Poriau S, De Wilde F, Verbruggen G. Joos R, et al. Among authors: mielants h. Clin Exp Rheumatol. 1987;5 Suppl 1:S41-7. Clin Exp Rheumatol. 1987. PMID: 3498598
Current concepts in psoriatic arthritis.
Veys EM, Mielants H. Veys EM, et al. Among authors: mielants h. Dermatology. 1994;189 Suppl 2:35-41. doi: 10.1159/000246987. Dermatology. 1994. PMID: 7841553 Review.
Spondylarthropathies: from gut to target organs.
Veys EM, Mielants H, De Vos M, Cuvelier C. Veys EM, et al. Among authors: mielants h. Baillieres Clin Rheumatol. 1996 Feb;10(1):123-46. doi: 10.1016/s0950-3579(96)80009-4. Baillieres Clin Rheumatol. 1996. PMID: 8674144 Review.
264 results